Skip to main content
SpringerLink
Log in

ASO Author Reflections: C-Reactive Protein/Lymphocyte Ratio as a Promising Marker for Predicting Survival in Pancreatic Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.

    Article  Google Scholar 

  2. Liu Z, Jin K, Guo M, et al. Prognostic value of the CRP/Alb ratio, a novel inflammation-based score in pancreatic cancer. Ann Surg Oncol. 2016;24:561–568.

    Article  Google Scholar 

  3. Fan Z, Luo G, Gong Y, et al. Prognostic value of the CRP/lymphocyte ratio in pancreatic cancer. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08301-3.

    Article  PubMed  Google Scholar 

  4. Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 2019;51:27–41.

    Article  CAS  Google Scholar 

  5. Okugawa Y, Toiyama Y, Yamamoto A, et al. Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer. Ann Surg. Epub 16 Feb 2019. https://doi.org/10.1097/SLA.0000000000003239.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (Grant Nos. 81625016, 81871940, 81902417), the Shanghai Natural Science Foundation (Grant No. 17ZR1406300), the Shanghai Cancer Center Foundation for Distinguished Young Scholars (Grant No. YJJQ201803), and the Fudan University Personalized Project for “Double Top” Original Research (Grant No. XM03190633).

Author information

Author notes

  1. Zhiyao Fan, Guopei Luo and Yitao Gong have contributed equally to this work.

Authors and Affiliations

  1. Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China

    Zhiyao Fan MD, Guopei Luo MD, PhD, Yitao Gong MD, Chen Liu MD, PhD & Xianjun Yu MD, PhD

  2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China

    Zhiyao Fan MD, Guopei Luo MD, PhD, Yitao Gong MD, Chen Liu MD, PhD & Xianjun Yu MD, PhD

  3. Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China

    Zhiyao Fan MD, Guopei Luo MD, PhD, Yitao Gong MD, Chen Liu MD, PhD & Xianjun Yu MD, PhD

  4. Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China

    Zhiyao Fan MD, Guopei Luo MD, PhD, Yitao Gong MD, Chen Liu MD, PhD & Xianjun Yu MD, PhD

Authors
  1. Zhiyao Fan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guopei Luo MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yitao Gong MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chen Liu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xianjun Yu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Chen Liu and Xianjun Yu designed the study, and Zhiyao Fan, Yitao Gong, and Guopei Luo performed the statistical analysis. All authors collected the clinical data and drafted the manuscript. Xianjun Yu and Chen Liu critically reviewed the manuscript, and all authors read and approved the final version.

Corresponding authors

Correspondence to Chen Liu MD, PhD or Xianjun Yu MD, PhD.

Ethics declarations

Disclosures

Zhiyao Fan, Guopei Luo, Yitao Gong, Chen Liu, and Xianjun Yu declare no conflict of interest in this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fan, Z., Luo, G., Gong, Y. et al. ASO Author Reflections: C-Reactive Protein/Lymphocyte Ratio as a Promising Marker for Predicting Survival in Pancreatic Cancer. Ann Surg Oncol 27, 4026–4027 (2020). https://doi.org/10.1245/s10434-020-08335-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08335-7

Search

Navigation